Article Text

This article has a correction. Please see:

Download PDFPDF
The Scotland and Newcastle epidemiological study of Hodgkin’s disease: impact of histopathological review and EBV status on incidence estimates
  1. R F Jarrett1,
  2. A S Krajewski2,
  3. B Angus3,
  4. J Freeland1,
  5. P R Taylor4,
  6. G M Taylor5,
  7. F E Alexander6
  1. 1LRF Virus Centre, Institute of Comparative Medicine, University of Glasgow, Glasgow G61 1QH, UK
  2. 2Department of Pathology, Northampton General NHS Trust, Northampton NN1 5BD, UK
  3. 3Department of Pathology, University of Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UK
  4. 4Department of Haematology, University of Newcastle upon Tyne
  5. 5Immunogenetics Laboratory, University of Manchester, St Mary’s Hospital, Manchester M13 0JH, UK
  6. 6Department of Community Health, Public Health Sciences, University of Edinburgh, Medical School, Teviot Place, Edinburgh EH8 9AG, UK
  1. Correspondence to:
 Professor R F Jarrett
 LRF Virus Centre, Institute of Comparative Medicine, Faculty of Veterinary Medicine, University of Glasgow, Glasgow, G61 1QH, UK; r.f.jarrettvet.gla.ac.uk

Abstract

Aims: The epidemiological and pathological features of Hodgkin lymphoma (HL) are complex. The Epstein-Barr virus (EBV) is consistently associated with a proportion of cases, and these cases are thought to represent a distinct aetiological subgroup of HL. The aim of the present analysis was to determine the age and sex specific incidence of EBV associated and non-associated HL, analysed separately, using data derived from a population based study–the Scotland and Newcastle epidemiological study of Hodgkin’s disease (SNEHD). This study also provided a unique opportunity to evaluate accuracy in the current diagnosis and classification of HL.

Methods: SNEHD analysed consecutive cases of HL diagnosed in the study area between 1993 and 1997. Diagnostic biopsy material was retrieved, EBV status of tumours was determined, and histological review was performed.

Results: In total, 622 cases were eligible for the study, and EBV studies and histopathological review were performed on biopsy material from 537 and 549 cases, respectively. Accuracy in the overall diagnosis of HL and classification of nodular sclerosis HL was good, but diagnosis of HL in the elderly and classification of other subtypes was less reliable. One third of classic HL cases were EBV associated, and age specific incidence curves for EBV associated and non-associated cases were distinct.

Conclusions: Comparison of age specific incidence curves for EBV associated and non-associated HL supports the hypothesis that these are two distinct aetiological entities. Accuracy in the diagnosis of HL is generally good, but certain subgroups of cases continue to present diagnostic difficulties.

  • Hodgkin lymphoma
  • human herpesvirus 4
  • epidemiology
  • histopathological review
  • CHL, classic Hodgkin lymphoma
  • EBER, Epstein-Barr virus encoded RNA
  • EBV, Epstein-Barr virus
  • HL, Hodgkin lymphoma
  • HRS, Hodgkin and Reed-Sternberg
  • IHC, immunohistochemistry
  • IM, infectious mononucleosis
  • LMP1, latent membrane protein 1
  • LDHL, lymphocyte depleted Hodgkin lymphoma
  • LRCHL, lymphocyte rich classic Hodgkin lymphoma
  • MCHL, mixed cellularity Hodgkin lymphoma
  • NHL, non-Hodgkin lymphoma
  • NLPHL, lymphocyte predominant Hodgkin lymphoma
  • NOS, not otherwise specified
  • NSHL, nodular sclerosing Hodgkin lymphoma
  • SNEHD, Scotland and Newcastle epidemiological study of Hodgkin’s disease
  • SNLG, Scotland and Newcastle lymphoma group

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

Linked Articles

  • Correction
    BMJ Publishing Group Ltd and Association of Clinical Pathologists